These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 7267470)

  • 61. Diffuse scleroderma and Raynaud's disease.
    JABLONSKA S; BUBNOW B; SZCZEPANSKI A
    Br J Dermatol; 1962 May; 74():174-82. PubMed ID: 14450537
    [No Abstract]   [Full Text] [Related]  

  • 62. Differential diagnosis of sclerodermoid skin changes.
    Chanda JJ; Callen JP
    Cutis; 1978 Jun; 21(6):843-7, 871. PubMed ID: 657841
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pathogenesis of scleroderma. Current concepts.
    Lee EB; Anhalt GJ; Voorhees JJ; Diaz LA
    Int J Dermatol; 1984 Mar; 23(2):85-9. PubMed ID: 6698691
    [No Abstract]   [Full Text] [Related]  

  • 64. What is your diagnosis? Progressive systemic sclerosis (scleroderma).
    Elston DM
    Cutis; 2005 Dec; 76(6):357, 385-7. PubMed ID: 16438423
    [No Abstract]   [Full Text] [Related]  

  • 65. Inflammatory morphea in the context of Raynaud phenomenon.
    Abbasi N; Firoz B; Bossenbroek NM; Meehan SA; Kamino H; Franks AG
    Dermatol Online J; 2008 Oct; 14(10):11. PubMed ID: 19061610
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pathogenesis and treatment modalities of localized scleroderma.
    Valančienė G; Jasaitienė D; Valiukevičienė S
    Medicina (Kaunas); 2010; 46(10):649-56. PubMed ID: 21393982
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group.
    Avouac J; Fransen J; Walker UA; Riccieri V; Smith V; Muller C; Miniati I; Tarner IH; Randone SB; Cutolo M; Allanore Y; Distler O; Valentini G; Czirjak L; Müller-Ladner U; Furst DE; Tyndall A; Matucci-Cerinic M;
    Ann Rheum Dis; 2011 Mar; 70(3):476-81. PubMed ID: 21081523
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Differential diagnosis of scleroderma-like changes in the skin].
    Pokorný M
    Cesk Dermatol; 1973 Oct; 48(5):347-50. PubMed ID: 4762465
    [No Abstract]   [Full Text] [Related]  

  • 69. Scleroderma of the Hand: Evaluation and Treatment.
    Beldner S; Rabinovich RV; Polatsch DB
    J Am Acad Orthop Surg; 2020 Aug; 28(16):e686-e695. PubMed ID: 32769717
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Epidemiology and pathogenesis of scleroderma.
    Chen K; See A; Shumack S
    Australas J Dermatol; 2003 Feb; 44(1):1-7; quiz 8-9. PubMed ID: 12581091
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Role of esophageal manometry in the diagnosis and developmental control of scleroderma].
    Balanzoni S; Bagioni P; Bacchilega R; Catrani S
    Minerva Dietol Gastroenterol; 1985; 31(2):183-90. PubMed ID: 4034026
    [No Abstract]   [Full Text] [Related]  

  • 72. Endothelin and collagen vascular disease: a review with special reference to Raynaud's phenomenon and systemic sclerosis.
    Yamane K
    Intern Med; 1994 Oct; 33(10):579-82. PubMed ID: 7827371
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pseudoscleroderma and scleroderma-like states].
    Thivolet J
    Rev Prat; 1975 May; 25(25):1959-63. PubMed ID: 1135585
    [No Abstract]   [Full Text] [Related]  

  • 74. Paediatric morphoea: a holistic review. Part 2: diagnosis, measures of disease activity, management and natural history.
    Kaushik A; Mahajan R; De D; Handa S
    Clin Exp Dermatol; 2020 Aug; 45(6):679-684. PubMed ID: 32449205
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Red flags in scleroderma.
    Li Q; Sahhar J; Littlejohn G
    Aust Fam Physician; 2008 Oct; 37(10):831-4. PubMed ID: 19002303
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [How I explore ... the skin functional involvement in scleroderma].
    Hermanns-Lê T; Piérard-Franchimont C; Piérard GE; André B; De Roover C; Renwart L; Delvenne P
    Rev Med Liege; 2013 Mar; 68(3):141-7. PubMed ID: 23614323
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Pathohistological and histochemical changes in the skin of patients with scleroderma during treatment at the Sochi spa].
    Al'ter SM
    Vestn Dermatol Venerol; 1971 Oct; 45(10):40-3. PubMed ID: 5134077
    [No Abstract]   [Full Text] [Related]  

  • 78. Scleroderma.
    Miller M
    Aust Fam Physician; 1993 Dec; 22(12):2112-9. PubMed ID: 8304869
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Raynaud's phenomenon and scleroderma.
    Harper FE; LeRoy EC
    Compr Ther; 1981 Feb; 7(2):45-51. PubMed ID: 6163587
    [No Abstract]   [Full Text] [Related]  

  • 80. Diagnostic significance of nailfold bleeding in scleroderma spectrum disorders.
    Sato S; Takehara K; Soma Y; Tsuchida T; Ishibashi Y
    J Am Acad Dermatol; 1993 Feb; 28(2 Pt 1):198-203. PubMed ID: 8432916
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.